Joyce Reyes - 01 Jun 2022 Form 3 Insider Report for Histogen Inc.

Role
Senior Vice President of Regulatory, Quality and Technical Operations
Signature
/s/ Susan A. Knudson as attorney-in-fact for Joyce Reyes
Issuer symbol
N/A
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
3
Filing time
03 Jun 2022, 16:28:50 UTC
Next filing
28 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HSTO Stock Option (right to buy) 01 Jun 2022 Common Stock 1,200 $4.80 Direct F1, F2
holding HSTO Stock Option (right to buy) 01 Jun 2022 Common Stock 4,451 $4.80 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amounts of securities reported on this Form 3 and the exercise prices have been adjusted to reflect the Reverse Stock Split.
F2 1/4 of the shares subject to the option vest one year after the date of grant, on 9/15/2022, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
F3 1/4 of the shares subject to the option vest one year after the date of grant, on 2/17/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.

Remarks:

Senior Vice President of Regulatory, Quality and Technical Operations